Image Trademark with Serial Number 87824828![Image for trademark with serial number 87824828](/media/image.php?serial=87824828)
Status: 700 - Registered
Serial Number
87824828
Registration Number
5754634
Status
700 - Registered
Status Date
2019-05-21
Filing Date
2018-03-07
Registration Number
5754634
Registration Date
2019-05-21
Mark Drawing
2000 - Illustration: Drawing or design without any word(s)/letter(s)/ number(s)
Typeset
Design Searches
260121, 261706 - Circles that are totally or partially shaded. Diagonal line(s), band(s) or bar(s).
Published for Opposition Date
2019-03-05
Attorney Name
Law Office Assigned Location Code
N80
Employee Name
BEAUDRY-TORRES, FAITH
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of a shaded circle with four diagonal narrowing notches inside of it.
Goods and Services
Pharmaceutical and medicinal preparations and substances for the treatment of cancer, thrombosis, embolisms, inflammation, autoimmune diseases, and envenomation by snakes; veterinary preparations and substances for the treatment of envenomation by snakes; sanitary preparations for medical purposes; dietetic foods adapted for medical use; vaccines; antitoxic sera; medical diagnostic reagents and substances, all for in vivo use; Antibodies being therapeutic antibodies for use as anti-lymphocytic agents; pharmaceutical preparations in the form of foams or for use in producing foams for the treatment of sclerotherapy, phlebology, angiology or proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; chemical reagents for medical or veterinary purposes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes, methotrexate toxicity, 5-fluorouracil toxicity; chemico-pharmaceutical preparations for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for use in the prevention and treatment of cancer, circulatory system issues and conditions, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, intracranial hemorrhages, cerebral hemorrhages, hematomas, and as antidotes; pharmaceutical preparations for the treatment of cancer; pharmaceutical and veterinary preparations for the reduction or elimination of circulating cytokines; pharmaceutical and veterinary preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; pharmaceutical and veterinary preparations for treatment of envenomation by snakes; pharmaceutical preparations for the treatment of methotrexate toxicity; pharmaceutical preparations for the treatment of immune disorders; pharmaceutical preparations for the treatment of cancer including prostate, oesophageal and brain cancer and leukaemias; pharmaceutical preparations for the treatment of sepsis; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations and substances for use in the circulatory system; pharmaceutical preparations and substances for embolization; pharmaceutical preparations and substances for embolization of tumours and arteriovenous malformations (AVMs); pharmaceutical preparations and substances for use in the circulatory system for the treatment of tumours and AVMs; adjuvants for medicinal purposes, vaccine adjuvants and vaccine preparations containing adjuvant; chemical reagents for medical or veterinary purposes for the treatment of envenomation by snakes; chemical reagents for therapeutic and diagnostic purposes for the treatment of envenomation by snakes; chemical preparations for medical or pharmaceutical purposes for the treatment of envenomation by snakes; medicines for the treatment of envenomation by snakes; pharmaceutical and veterinary preparations for the treatment of pre-eclampsia; chemical reagents for medical or veterinary therapeutic and medical diagnostic purposes; chemico-pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; chemical preparations for medical or pharmaceutical purposes and medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; transarterial chemoembolization pharmaceutical preparations, vaccines and antitoxic sera; pharmaceutical preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; irradiated or radioactive microspheres used for in vivo therapeutic medical purposes; radiotherapy substances for medical purposes, namely, radioactive pharmaceutical preparations for medical purposes for the treatment of cancer; radiopharmaceuticals, namely, radiopharmaceuticals for the treatment of cancer and radiopharmaceutical preparations for use in nuclear medicine; therapeutic agents for delivery of radioactive material to target sites within the body; pharmaceutical preparations, being beads, including microscopic radioactive beads, for treatment of cancerous tumours; pharmaceutical preparations, being beads, including microscopic glass beads, impregnated with radioactive material for treatment of cancerous tumours; pharmaceutical preparations, being beads, namely, radioactive glass beads; pharmaceutical preparations for use with ultrasound waves to enhance drug delivery and/or medically activate drugs; pharmaceutical preparations in the form of foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams for use in producing foams for use in sclerotherapy treatment of veins; pharmaceutical preparations in the form of foams or for use in producing foams for sclerotherapy, phlebology, angiology and proctology, for treatment of oesophageal varices, hydroceles, in sterilisation treatment or for treatment of varicose veins, or arterio-venous malformations; pharmaceutical preparations containing methotrexate antidotes for the treatment of methotrexate toxicity; pharmaceutical preparations containing 5-fluorouracil antidotes for the treatment of 5-fluorouracil toxicity; pharmaceutical preparations for use in chemotherapy and autoimmune diseases; pharmaceutical preparations used for regulating toxicity levels of therapeutic agents; pharmaceutical preparations used for depleting concentrations of therapeutic agents
Goods and Services
Surgical, medical, dental and veterinary apparatus and instruments, namely, cryoablation needles, medical syringes, electrically powered tissue ablation devices, surgical and medical apparatus and instruments for the treatment and prevention of varicose veins, arterio-venous malformations, oesophageal varices, hydroceles, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions and coronary vascular lesions, devices for intravenous administration of pharmaceutical foam, and diagnostic devices for grading the severity of venous conditions, snake envenomation and toxic drugs overdose, surgical and medical apparatus and instruments for use in minimally invasive cryoablation procedures; artificial limbs; orthopaedic articles, namely, implants made of artificial materials; medical syringes, medical cannula needles, medical tubing; surgical and medical apparatus for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical or medical apparatus for producing foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; surgical and medical devices for assessing the physical characteristics of foams for use in sclerotherapy, phlebology, angiology or proctology, sterilisation treatment or for treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices or hydroceles, namely, devices for intravenous administration of foam and devices for monitoring the position and effect of foam in the human body; medical diagnostic devices for diagnosing, varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; haemofiltration devices for medical use; drug delivery embolisation apparatus, instruments and devices; apparatus and instruments for use in the circulatory system; apparatus and instruments for embolisation; surgical and medical apparatus and instruments, namely, catheters, injection syringes and sealed vial devices for dispensing microspheres during embolisation procedures in blood vessels and in the circulatory system; embolisation apparatus, instruments and systems, namely, surgical and medical instruments for embolisation; drug delivery embolisation devices and instruments; drug delivery apparatus and instruments comprised of injection syringes, and sealed vials; injection syringes for use with catheters; apparatus and instruments for use in the circulatory system, namely, catheters, injection syringes and sealed vials; medical apparatus and instruments for embolisation; surgical and medical apparatus and instruments for embolisation, namely, embolisation apparatus, instruments and systems comprising microspheres and injection syringes for use in blood vessels and the circulatory system to carry out embolisation; radiotherapy apparatus; surgical and medical apparatus and instruments for delivery of radiopharmaceuticals and radioactive material to target sites within the body; beads, namely, microscopic glass beads, impregnated with radioactive material or containing radioactive material and administered surgically for treatment of cancerous tumours; radioactive beads, namely, radioactive glass beads administered for treatment of cancerous tumours; surgical and medical apparatus and instruments for use in the circulatory system; medical devices which use ultrasound to enhance drug delivery and/or medically activate drugs; catheters for delivery of drugs or fluids sold together as a unit with controllers and power units for infusion catheters; ultrasonic drug delivery and drug activation apparatus sold together as a unit with controllers and power units therefor; needles for medical use, namely, cannula needles; medical tubing for sclerotherapy; medical tubing for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; surgical and medical apparatus for producing and administering sclerosing foams for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; syringes for producing and administering foams for use in sclerotherapy, phlebology, angiology or proctology; surgical and medical apparatus for administering and producing foams for use in sterilisation treatment; surgical and medical apparatus for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hycroceles; syringes for use in treatment of varicose veins, arterio-venous malformations, oesophageal varices or hydroceles; medical devices for assessing the physical characteristics of sclerosing foams; medical devices for intravenous administration of sclerosing foam for the treatment of varicose veins, venous malformations, arterio-venous malformations, oesophageal varices and hydroceles; medical devices for monitoring the position and effect of foam in the human body; medical diagnostic apparatus for diagnosing varicose veins, arterio-venous malformations, oesophageal varices, spider veins hydroceles, cancer, tumors, and circulatory system conditions and pulmonary and thoracic conditions; compression bandages; surgical apparatus and instruments, medical devices and medical diagnostic apparatus and instruments for use in interventional pulmonology; medical devices for use in pulmonary and thoracic surgery and procedures; lung volume reduction medical devices; artificial surgical implants for use in interventional pulmonology; surgical implants comprising artificial surgical implants for restoring, maintaining and improving patient breathing, and artificial surgical implants for restoring, maintaining and improving lung function; catheters for use in cardiology; catheters for use in the treatment of arterial diseases; cryoablation needles for medical use; Medical apparatus and instruments, namely, cryoablation apparatus for the treatment of tumours and management of pain; replacement and structural parts and fittings for all of the aforesaid goods
Goods and Services
Education, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; providing online databases featuring education information about medical education in the fields of healthcare, the use of pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; education services, namely, providing instruction, workshops, seminars, continuing education and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; arranging, and conducting educational conferences and programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; provision and publication of educational material and content, namely, teaching guides, instructional materials, brochures and pamphlets in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; providing on-line non-downloadable publications in the nature of teaching guides, instructional materials, brochures and pamphlets in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care; providing online, non-downloadable electronic publications, namely, patient reported outcome questionnaires in the fields of healthcare, medicine, medical treatment and patient care; conducting educational seminars in the fields healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care and distribution of course materials therewith; information and advice relating to educational training provided online from a computer database or the internet, all relating to healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-03-14
Primary Code
005
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2018-03-14
Primary Code
010
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2018-03-14
Primary Code
041
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
24
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
24
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (private limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Jonathan A. Hyman
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 3859364 |
Prior Registration | 4848446 |
Prior Registration | 4962341 |
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2017-11-03 | 3268079 | United Kingdom | True |
Trademark Events
Event Date | Event Description |
2018-03-10 | NEW APPLICATION ENTERED IN TRAM |
2018-03-12 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2018-03-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2018-03-15 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
2018-03-14 | TEAS VOLUNTARY AMENDMENT RECEIVED |
2018-03-29 | ASSIGNED TO LIE |
2018-03-29 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
2018-04-02 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
2018-06-19 | ASSIGNED TO EXAMINER |
2018-06-19 | ASSIGNED TO EXAMINER |
2018-06-28 | NON-FINAL ACTION WRITTEN |
2018-06-28 | NON-FINAL ACTION E-MAILED |
2018-06-28 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2018-12-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2018-12-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2018-12-14 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-01-15 | EXAMINERS AMENDMENT -WRITTEN |
2019-01-15 | EXAMINERS AMENDMENT E-MAILED |
2019-01-15 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2019-01-15 | EXAMINER'S AMENDMENT ENTERED |
2019-01-31 | EXAMINERS AMENDMENT -WRITTEN |
2019-01-31 | EXAMINERS AMENDMENT E-MAILED |
2019-01-31 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2019-01-31 | EXAMINER'S AMENDMENT ENTERED |
2019-01-31 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-02-13 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-03-05 | PUBLISHED FOR OPPOSITION |
2019-03-05 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-05-21 | REGISTERED-PRINCIPAL REGISTER |
2020-08-29 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2020-08-29 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2020-08-29 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-08-29 | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED |
2020-08-29 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-08-29 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2021-04-14 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2021-08-30 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2021-08-30 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2021-08-30 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2021-08-30 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2021-08-30 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |